Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure
about
SIRT3 deacetylates and activates OPA1 to regulate mitochondrial dynamics during stressThe Measurement of Reversible Redox Dependent Post-translational Modifications and Their Regulation of Mitochondrial and Skeletal Muscle FunctionReactive oxygen species in health and diseaseMitochondrial dysfunction in heart failureSepsis-induced Cardiac Mitochondrial Damage and Potential Therapeutic Interventions in the ElderlyMitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathyMitochondria as a therapeutic target in heart failureHeart failure and mitochondrial dysfunction: the role of mitochondrial fission/fusion abnormalities and new therapeutic strategiesMitochondria and cardiovascular agingMechanisms of altered Ca²⁺ handling in heart failurePathogenesis of target organ damage in hypertension: role of mitochondrial oxidative stressMitochondrial oxidative stress in aging and healthspanQuality control systems in cardiac agingPathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implicationsProtein quality control and metabolism: bidirectional control in the heartFirst-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergeticsCross talk between mitochondria and NADPH oxidasesTherapeutic inhibition of mitochondrial reactive oxygen species with mito-TEMPO reduces diabetic cardiomyopathyMitochondrial Calpain-1 Disrupts ATP Synthase and Induces Superoxide Generation in Type 1 Diabetic Hearts: A Novel Mechanism Contributing to Diabetic CardiomyopathyCardiac-specific hexokinase 2 overexpression attenuates hypertrophy by increasing pentose phosphate pathway fluxMitochondrial redox signaling: Interaction of mitochondrial reactive oxygen species with other sources of oxidative stressRole of circulating factors in cardiac aging.Impaired mitochondrial network excitability in failing guinea-pig cardiomyocytesEstablishment of a prediction model of changing trends in cardiac hypertrophy disease based on microarray data screening.FoxO proteins restrain osteoclastogenesis and bone resorption by attenuating H2O2 accumulation.Cytosolic H2O2 mediates hypertrophy, apoptosis, and decreased SERCA activity in mice with chronic hemodynamic overload.Valsartan regulates myocardial autophagy and mitochondrial turnover in experimental hypertensionHeart failure with preserved ejection fraction: molecular pathways of the aging myocardiumThe oxygen-rich postnatal environment induces cardiomyocyte cell-cycle arrest through DNA damage responseSuper-suppression of mitochondrial reactive oxygen species signaling impairs compensatory autophagy in primary mitophagic cardiomyopathy.Macrophage-stimulated cardiac fibroblast production of IL-6 is essential for TGF β/Smad activation and cardiac fibrosis induced by angiotensin IIReducing mitochondrial ROS improves disease-related pathology in a mouse model of ataxia-telangiectasia.Cardiomyocyte-specific deficiency of ketone body metabolism promotes accelerated pathological remodeling.Autophagy and oxidative stress in cardiovascular diseases.MiR-30-regulated autophagy mediates angiotensin II-induced myocardial hypertrophyActivation of liver X receptor improves viability of adipose-derived mesenchymal stem cells to attenuate myocardial ischemia injury through TLR4/NF-κB and Keap-1/Nrf-2 signaling pathways.In vitro effects of exercise on the heart.Regulation of Monocyte Adhesion and Migration by Nox4The mitochondrial dynamism-mitophagy-cell death interactome: multiple roles performed by members of a mitochondrial molecular ensemble.Cardiac steatosis potentiates angiotensin II effects in the heart.
P2860
Q24313709-5F55FCC5-82F1-418A-A764-7328090A827BQ26774769-7EC62C31-7DB8-4548-BBE5-8176A8A8BE44Q26851203-2065B076-0430-4BE6-887D-275CC23B233BQ26851293-43661781-D93E-4558-BA46-21CF25ADF5E8Q26853544-258EC55B-1AF3-4CDB-9FEB-9F282A127A17Q26859582-93CDC905-4FB9-4DC8-B8ED-5C99D72E853DQ27005632-1815C88F-AA88-496A-88EC-25BB79D70AEDQ27005955-FCED87CA-9709-4965-A932-AC7F40BFF5F3Q27011752-CB0FDFB1-773C-49EC-9FDD-FD325F0C3DE8Q27012758-DEFFC09E-272B-4BEB-A60D-7D826DF1E050Q27015633-C6970964-2456-41B1-A7B4-DD98B385D3BBQ27025099-7157815D-1555-4E83-954C-2EDF7AF5B9DFQ28084341-9B889F83-548F-4707-AD12-2D49052A1F62Q28085102-797AD550-AC2D-4D17-9264-F75496700425Q28256472-311A516C-7153-4F12-BC3A-2FD9AE7367C8Q28383451-D5F2FF10-D40F-4107-9580-3E026E007B17Q28391403-C1C95D97-D442-4E06-9280-FEC1F3CEFF6AQ28391746-530A6E4A-F5FB-4565-B5FA-1A680EEE75C3Q28397064-5AFBB2EC-6BF4-431D-9B6D-41B695F52703Q28572802-31FB9D35-AF4B-4AAB-B64A-2DC2E4A98F92Q28660732-7D886C2A-AFFE-45D5-B151-BA59074F9846Q30234641-96FC222E-43C8-49A4-8180-A0550F4967C9Q30692654-A80A1230-F0A6-42CC-8F6E-79ED2BE3F6A4Q31095420-7D828CC0-7A62-4FF4-B547-47419454492FQ33587373-1EFE1105-1E20-4203-A0EB-A930657D604EQ33626525-128877D7-3D48-4201-B912-59EB273BB7C8Q33754050-C1989B00-9EF6-4F30-A537-42D3543E56CBQ33889242-EFF9BB67-FD49-4354-A229-A79320C4D20EQ33924341-E38F38B3-2586-4FF2-8665-B8877E3021E8Q33931661-FAAA4FA1-BB1F-4666-990E-4894C1EB7FF8Q34264496-87131D01-0BA9-46AE-83EA-06DE5E33067EQ34301883-1ECEA38E-CCB3-440E-A997-4533B9F4338BQ34404106-9F0E3D75-BC1C-46D7-8D52-3C67C53C1032Q34506174-1D74F5D6-37C2-4FFA-998E-8EBEBAD4277BQ34551993-591C70C4-2C3B-4DB2-80B6-9C8E2934EE9EQ34579503-5B71418F-1224-4A6A-AC01-3BBCBC38972BQ34615041-B6B25E84-5918-4691-92E3-104B00954E5CQ34794515-4029CDFB-2CD6-4FC5-AEED-CB402455C98DQ34807191-C30ED988-B2E4-439D-8B81-3717E535FE4EQ35086438-955225F8-DCFA-4157-8D52-E3B06ABC07A5
P2860
Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mitochondrial oxidative stress ...... pression-induced heart failure
@en
Mitochondrial oxidative stress ...... ression-induced heart failure.
@nl
type
label
Mitochondrial oxidative stress ...... pression-induced heart failure
@en
Mitochondrial oxidative stress ...... ression-induced heart failure.
@nl
prefLabel
Mitochondrial oxidative stress ...... pression-induced heart failure
@en
Mitochondrial oxidative stress ...... ression-induced heart failure.
@nl
P2093
P2860
P50
P921
P1433
P1476
Mitochondrial oxidative stress ...... pression-induced heart failure
@en
P2093
Gerald W Dorn
Jason J Villarin
Madeline Nieves-Cintrón
Michael T Chin
Simon C Johnson
Tomas A Prolla
Y James Kang
P2860
P304
P356
10.1161/CIRCRESAHA.110.232306
P577
2011-02-10T00:00:00Z